DoximityDOCS +1.71%82 Buyback Yield % is 11.53 as of Jun. 25, 2026, which is 742% above its 10-year median of 1.37. GuruFocus rates DOCS with a GF Score™ of 82/100 and a GF Value™ of $49.17 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 271 Healthcare Providers & Services companies, Doximity ranks better than 98.15% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Doximity's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DOCS vs WAY, TXG, HNGE: Buyback Yield % Comparison
For the Health Information Services subindustry, Doximity's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Doximity Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Doximity's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Doximity's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Doximity (DOCS) has a Buyback Yield % of 11.53 as of Jun. 25, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Doximity and its competitors. This is 742% above median its historical median of 1.37. According to the industry distribution chart, Doximity ranks #5 out of 271 companies in the Healthcare Providers & Services industry, placing it in the top 1.8%.
Is Doximity's Buyback Yield % too high?
Doximity's current Buyback Yield % of 11.53 is 742% above median its 10-year median of 1.37. Based on the distribution chart, Doximity ranks #5 out of 271 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Doximity has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Doximity's Buyback Yield % compare to WAY and TXG?
According to the Healthcare Providers & Services industry distribution chart, Doximity ranks #5 out of 271 companies for Buyback Yield %. This places Doximity in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Doximity and its competitors. Doximity's current Buyback Yield % is 11.53, which is 742% above median its own 10-year median of 1.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doximity stock overvalued right now?
Based on GuruFocus' analysis, Doximity (DOCS) is currently considered Significantly Undervalued. The stock's GF Value™ is $49.17, compared to a current price of $20.83 — trading 57.6% below its estimated fair value. The current Buyback Yield % is 11.53, which is 742% above median its 10-year median of 1.37. Doximity's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Doximity (DOCS), the current Buyback Yield % is 11.53 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Doximity (DOCS) Overvalued in 2026?
Based on GuruFocus' analysis, Doximity stock appears to be undervalued.
The current stock price of $20.83 is trading 57.6% below its estimated GF Value™ of $49.17.
GuruFocus considers Doximity to be Significantly Undervalued.
Key valuation signals for DOCS:
Buyback Yield %: 11.53 (742% above median its 10-year median of 1.37)
GF Value™: $49.17 vs. price of $20.83 (57.6% below fair value)
No single metric tells the full story. See the DOCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
82GF Score
Get the complete analysis for DOCS
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCS has been successfully added to your 
